Roswell Park Comprehensive Cancer Center
Latest from Roswell Park Comprehensive Cancer Center
Experts Make the Case for Buprenorphine Use in Cancer-Related Pain Management
June 28, 2022
Article
Mary Lynn McPherson, PharmD, BCPS, FAAHPM, and Amy A. Case, MD, FAAHPM, argue that buprenorphine should play a larger role in cancer-related pain management because of its unique pharmacology and consequent safety profile.
Nurse Takeaways: How to Improve a Patient’s Experience With Sotorasib and Optimize NSCLC Treatment
May 26, 2022
Article
Oncology nurses present their experiences treating patients with sotorasib in the phase 1/2 CodeBreaK 100 trial and optimal symptom management strategies to improve patient outcomes with the drug.
Will Requiring the DNP Improve the Quality of Oncology Nursing?
April 22, 2022
Article
Advocacy and opposition continue to grow regarding the National Organization of Nurse Practitioner Faculties’ goal of requiring the Doctor of Nursing Practice degree (DNP) for entry-level nurse practitioners.
2-Year Follow-Up Showcases Sotorasib Benefit in KRAS G12C+ NSCLC
April 15, 2022
Article
Longer follow-up data from the phase 1/2 CodeBreaK 100 trial show that patients with KRAS G12C–mutant non–small cell lung cancer experienced improved prolonged overall survival and encouraging response rates with sotorasib.
New Dosing Guide Will Maximize Buprenorphine Benefit Without Putting Patients at High Risk of Addiction
February 10, 2022
Article
Experts from Roswell Park developed a dosing guide for the prescription of buprenorphine as treatment for chronic pain.
Roswell Park Nurse Residency Program Nationally Recognized and Accredited
September 30, 2021
Article
With education one of the cornerstones of its mission, Roswell Park Comprehensive Cancer Center is pleased to announce that its Nurse Residency Program has achieved Accreditation with Distinction from the American Nurses Credentialing Center (ANCC).